Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results - Qin, C; Tian, D S; Zhou, L Q (Signal Transduct Target Ther, 2023)